Parallelly, KEGG-enriched signaling pathways included human T-cell leukemia virus type 1 infection, the T cell receptor signaling pathway, PD-L1 expression and the PD-1 checkpoint pathway in cancer, TH17 cell differentiation and other immune-related signaling pathways. This evidence concerns the gene CD274 and cancer.